GAPVelocity AI, the AI modernization business unit of Growth Acceleration Partners (GAP), today announced the upcoming launch of VELOtm, the industry's first agentic AI platform purpose-built for ...
A modern digital platform is incomplete if it is not mobile-first. Though mobile access may seem innocuous at first, it often serves to build trust through usability and improve the overall experience ...
The Santa Monica City Council has authorized a sweeping reassessment of how the city addresses homelessness and affordable housing, directing staff to begin community outreach on a potential shift to ...
The White House has announced a national legislative framework for artificial intelligence. It comes down in favor of federal regulations rather than a patchwork of conflicting state laws. It is the ...
The White House released a new framework for national AI legislation Friday morning, focusing on protections for children and boosting the industry while calling for sharp limits on legal liability ...
OX Agentic Pentester uses AI-driven attack simulation to show what attackers can exploit — and exactly where to fix it in code NEW YORK, March 12, 2026 /PRNewswire/ -- OX Security today announced OX ...
If you’ve spent any time around the Fargo–Moorhead fishing community — whether at an FM Walleyes seminar, a Pelican Rapids tournament weigh‑in, or just talking shop at the Scheels bait aisle — you’ve ...
LONDON, March 6 (Reuters) - Britain should reject any move to let artificial intelligence companies freely mine copyrighted material for commercial model training and instead adopt a licensing-first ...
The Claude Code Figma MCP introduces a significant update to design and development workflows, allowing users to push UI designs created in Claude Code directly back to Figma. This two-way integration ...
A long-awaited Medicare add-on billing code not only boosted pay for primary care physicians but also helped specialists, researchers found in a new JAMA study that’s likely to reignite debate over ...
Topline results from BOND-003 cohort P: A multi-national, single-arm study of intravesical cretostimogene grenadenorepvec for treatment of high-risk, papillary only, BCG-unresponsive non-muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results